Charcoal agar interference in antibiotic susceptibility testing of Bordetella pertussis: evaluation and alternative methodologies
Authors:
Open Access
- 26 March 2026
- journal article
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 25 (1)
Abstract
Erythromycin-resistant Bordetella pertussis (ERBP) has increased sharply in China, posing significant challenges to clinical treatment. The lack of a standardized antimicrobial susceptibility testing (AST) system for B. pertussis makes it difficult to screen out effective antibiotics, which further aggravates the generation of drug-resistant strains and causes a vicious cycle. In this study, we modified a superior charcoal-free medium for antibiotic susceptibility testing, enabling more reliable evaluation of antibiotic efficacy. The minimum inhibitory concentrations (MICs) of erythromycin (E), trimethoprim-sulfamethoxazole (TMP-SMX), levofloxacin (LVF), and piperacillin (PIP) were determined using E-test strips on the agar plates with and without charcoal. The performance of these two media for AST was compared to establish a more accurate laboratory detection method. Subsequently, the superior charcoal-free medium was used to assess the antibiotic susceptibility of 98 B. pertussis strains isolated from clinical specimens after the COVID-19 pandemic, analyzing the sensitivity distribution of these first-line and alternative antibiotics. The MIC values of TMP-SMX and LVF were significantly higher on charcoal-containing agar plates than on charcoal-free medium. E-test results revealed that the MICs of B. pertussis strains to TMP-SMX and LVF had increased by approximately five gradient levels on the charcoal-containing agar compared to charcoal-free agar. Quality control (QC) testing demonstrated that the MICs of TMP/SMX and LVX fell outside the acceptable QC range due to adsorption by charcoal particles. Antimicrobial susceptibility of 98 B. pertussis clinical isolates showed that all strains were resistant to E with the MIC90 exceeded the maximum value (> 256 μg/mL). The overall MIC90 values for TMP-SMX, LVF and PIP were 1/0.75/<0.016 μg/mL on charcoal-containing agar and 0.023/0.008/<0.016 μg/mL on charcoal-free medium, respectively. Statistical analysis of violin plots confirmed that the MIC values of the second-line antibiotic TMP-SMX and LVF were significantly elevated on charcoal-containing agar. An accurate AST method can provide crucial guidance for optimal antibiotic selection in patients with B. pertussis infections. Our findings demonstrate that charcoal-free agar serves as an effective alternative medium for reliable AST of B. pertussis clinical isolates. The online version contains supplementary material available at 10.1186/s12941-026-00856-5.Keywords
Funding Information
- National Natural Science Foundation of China (Grant No. 82172312)
This publication has 40 references indexed in Scilit:
- Microbes know no borders: importation of macrolide-resistant Bordetella pertussis into France in 2024Clinical Microbiology and Infection, 2025
- Severe macrolide-resistant Bordetella pertussis (ptxP3) infection in Japanese infants: First report of cases requiring intensive careInternational Journal of Infectious Diseases, 2025
- Expert consensus for pertussis in children: new concepts in diagnosis and treatmentWorld Journal of Pediatrics, 2024
- Phenotypic diversity of Bordetella pertussis against Trimethoprim/Sulphamethoxazole in vitro testsDiagnostic Microbiology and Infectious Disease, 2024
- Carbon-based materials as efficient adsorbents for the removal of antibiotics: The real contributions of carbon edge sitesChemosphere, 2023
- Burden of Pertussis in Adults Aged 50 Years and Older: A Retrospective Database Study in EnglandInfectious Diseases and Therapy, 2023
- Emergence and spread of MT28 ptxP3 allele macrolide-resistant Bordetella pertussis from 2021 to 2022 in ChinaInternational Journal of Infectious Diseases, 2023
- Pharmacotherapy for Bordetella pertussis infection. I. A synthesis of laboratory sciencesInternational Journal of Antimicrobial Agents, 2021
- Clinical characteristics, molecular epidemiology and antimicrobial susceptibility of pertussis among children in southern ChinaWorld Journal of Pediatrics, 2019
- In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: A single-centre study in Zhejiang Province, ChinaJournal of Global Antimicrobial Resistance, 2019